A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Clinical trial NCT06349473 · RECRUITING

Trial details

NCT number: NCT06349473
Sponsor: Equilibra Bioscience LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Hemophilia A Hemophilia B Factor VII Deficiency

Start date: 2024-05-10
Primary completion: 2026-09-28
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.